Skip to main content
. 2020 Sep 4;11:1039. doi: 10.3389/fneur.2020.01039

Table 1.

The spectrum of neurological manifestations of SARS-CoV-2 infection.

Clinical finding No. of patients Author Country References
Headache 3/39 Huang et al. China (5)
9/138 Wang et al. China (6)
8/99 Chen et al. China (70)
28/214 Mao et al. China (10)
29/112 Porta-Etessam et al. Spain (73)
Dizziness 13/138 Wang et al. China (6)
36/214 Mao et al. China (10)
Loss of consciousness/altered mental status 9/99 Chen et al. China (70)
16/214 Mao et al. China (10)
Seizures 1/214 Mao et al. China (10)
Cerebrovascular disease 6/214 Mao et al. China (10)
3/58 Helms et al. France (84)
5 cases Oxley et al. United States (85)
Meningitis/encephalitis 1 case report Moriguchi et al. Japan (77)
1 case report Yin et al. China (76)
1 case report Duong et al. United States (78)
1 case report Filatov et al. United States (79)
1 case report Ye et al. China (80)
Olfactory and/or taste dysfunction 20/59 Giacomelli et al. Italy (92)
31/79 Beltrán-Corbellini et al. Spain (93)
128/169 Yan et al. United States (96)
130/374 Spinato et al. Italy (95)
357/417 Lechien et al. Belgium (66)
23/214 Mao et al. China (10)
2 cases Lorenzo Villalba et al. Spain (94)
Peripheral neuropathy/nerve pain 5/214 Mao et al. China (10)
Myopathy 23/214 Mao et al. China (10)
Guillain-Barre syndrome 1 case report Zhao et al. China (101)
1 case report Alberti et al. Italy (102)
1 case report Sedaghat et al. Iran (103)
5 cases Toscano et al. Italy (104)
Miller-Fisher syndrome 1 case report Gutierrez-Ortiz et al. Spain (115)
Neuropsychiatric manifestations 3 cases Ferrando et al. United States (114)

Other neurological manifestations reported in COVID-19 patients include ataxia, acute hemorrhagic necrotizing encephalopathy, polyneuritis cranialis, and neuralgia (10, 81).